ACETO Board of Directors Declares Quarterly Cash Dividend
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
ACETO Corp (ACET) Announces U.S. Launch of Generic Patanol
December 7, 2015 2:45 PM ESTACETO Corporation (NASDAQ: ACET) announced that Rising Pharmaceuticals, Inc., its finished dosage form generics subsidiary, is launching Olopatadine Hydrochloride 0.1% Ophthalmic Solution, an FDA-approved generic version of Alcon Inc.'s Patanol.
According to IMS Health data, U.S. market sales for Olopatadine Hydrochloride... More
ACETO Corp (ACET) Declares $0.06 Quarterly Dividend; 0.9% Yield
December 3, 2015 2:55 PM ESTACETO Corp (NASDAQ: ACET) declared a quarterly dividend of $0.06 per share, or $0.24 annualized.
The dividend will be payable on December 28, 2015, to stockholders of record on December 17, 2015, with an ex-dividend date of December 15, 2015.
The annual yield on the dividend is 0.9... More
